Home › Funds › Seven Fleet Capital Management LP › SLN
Seven Fleet Capital Management LP position in SLN
SILENCE THERAPEUTICS PLC · Health Care
Seven Fleet Capital Management LP reported holding 350,000 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.75% of its reported portfolio and ranking #24 among its reported holdings. Seven Fleet Capital Management LP has disclosed SLN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Seven Fleet Capital Management LP's SLN position evolved
Seven Fleet Capital Management LP first disclosed a stake in SLN in Q4 2025 at 147,600 shares (US$897K). The position peaked in Q3 2026 at 350,000 shares, worth US$3.8M. Across 4 filings, Seven Fleet Capital Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 350,000 shares valued at US$3.8M — an increase of 289,893 shares quarter over quarter.. Notable position changes include a 62% trim in Q2 2026 (shares were roughly flat over the following quarter), a 482% increase in Q3 2026 (shares rose 81% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 147.60K | $897.41K | New |
| Q1 2026 | 156.76K | $826.12K | Add |
| Q2 2026 | 60.11K | $659.98K | Reduce |
| Q3 2026 | 350.00K | $3.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLN and 13F data
SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 45 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$31.6M), Redmile Group, LLC (US$26.9M), Soleus Capital Management, L.P. (US$26.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLN
- Siren, L.L.C. 2.89M sh · $31.56M · Q3 2026
- Redmile Group, LLC 2.46M sh · $26.90M · Q3 2026
- Soleus Capital Management, L.P. 2.39M sh · $26.08M · Q3 2026
- TCG Crossover Management, LLC 1.82M sh · $19.88M · Q3 2026
- Nextech Invest Ltd. 1.69M sh · $18.51M · Q3 2026
- KVP Capital Advisors, LP 684.12K sh · $7.48M · Q3 2026
- Tetragon Partners GP Ltd 500.00K sh · $5.46M · Q3 2026
- 5AM Venture Management, LLC 476.20K sh · $5.20M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 393.58K sh · $4.30M · Q3 2026
- Fortress Investment Group LLC 230.00K sh · $2.51M · Q3 2026
- Sofinnova Investments, Inc. 211.80K sh · $2.31M · Q3 2026
- Squadron Capital Management LLC 180.00K sh · $1.97M · Q3 2026
More on Seven Fleet Capital Management LP
FAQ
How long has Seven Fleet Capital Management LP held SLN?
Seven Fleet Capital Management LP has disclosed SLN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Seven Fleet Capital Management LP's current position in SLN?
As of Q3 2026, Seven Fleet Capital Management LP holds 350.00K shares of SLN (SILENCE THERAPEUTICS PLC), valued at $3.83M, representing 0.75% of its reported portfolio and ranking #24.
Has Seven Fleet Capital Management LP been buying or selling SLN?
In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP increased its position in SLN. The position peaked in Q3 2026 at 350.00K shares.
Which other funds hold SLN?
Other major institutional holders of SLN include Siren, L.L.C., Redmile Group, LLC, Soleus Capital Management, L.P., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.